Angel News

Angel News

Back to Homepage

2nd November 2018

Shoosmiths advises Octopus Investments on clinical trial software deal

Shoosmiths has advised the intermediate capital team of Octopus Investments on its latest growth capital investment, into leading global clinical trial solutions provider Triumph Research Intelligence (TRI).


Register now to read full story

In order to read the full story we need you to register with us, please click the link below:

Register Now

Add a comment:




Enter the characters in the image shown:

Back to Homepage